We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Call Us Today!
Click here now
Click here now
Call Us Today!
Click here now
Click here now
Reduced bone density means the bones contain less mineral and may be weaker than expected. The condition can increase the risk of fractures involving the hip, spine, wrist, and other areas.
Bone loss is often called a silent condition because it may not cause pain or obvious symptoms before a fracture occurs. A man may not realize his bones have weakened until a minor fall causes a break or a spinal fracture leads to back pain or height loss.
Low bone density treatment depends on age, bone density results, fracture history, medications, hormone health, and overall fracture risk. Optimal Female & Men’s Wellness helps men identify possible contributors and determine whether nutrition, exercise, testosterone evaluation, medication management, or specialist care may be appropriate.
Bone is living tissue that is continuously removed and rebuilt. During early adulthood, the body generally replaces bone efficiently. With aging, bone breakdown may begin to occur faster than new bone formation.
Men often develop osteoporosis later than women, but the condition can still have serious consequences. Because routine screening is less consistent in men, reduced bone density may remain undetected until a fracture occurs.
Possible warning signs include unexplained height loss, new or persistent back pain, a curved posture, or a fracture caused by a fall from standing height. However, many men have no symptoms at all.
Age is an important risk factor, particularly after 70. A previous fracture from a minor fall also increases the likelihood of another fracture.
Other factors may include a family history of osteoporosis or hip fracture, smoking, heavy alcohol use, low body weight, inadequate nutrition, limited physical activity, and weak muscles.
Medical conditions that may affect bone include celiac disease, rheumatoid arthritis, diabetes, chronic kidney or liver disease, overactive thyroid or parathyroid conditions, and disorders that interfere with nutrient absorption.
Long-term use of corticosteroids can accelerate bone loss. Some seizure medications, cancer treatments, prostate-cancer therapies, and other prescriptions may also affect bone health.
A complete medication review is therefore an important part of evaluating reduced bone density in men.
Testosterone and estrogen both contribute to male bone strength. Men with medical conditions that cause significant testosterone deficiency may face a higher risk of reduced bone density and osteoporosis.
Possible signs of testosterone deficiency include low libido, fewer morning erections, reduced muscle mass, anemia, increased body fat, and low energy. Bone loss alone does not confirm low testosterone.
Testosterone deficiency generally requires compatible symptoms and consistently low testosterone measurements from separate morning blood tests.
Testosterone replacement therapy may improve bone density in appropriately diagnosed men, but it is not a universal low bone density treatment. A man with osteoporosis or a high fracture risk may still require an osteoporosis-specific medication even when low testosterone is also being treated.
A dual-energy X-ray absorptiometry scan, commonly called a DXA or DEXA scan, measures bone mineral density. The hip and spine are the areas most frequently assessed.
For men age 50 and older, results are usually reported as a T-score. A T-score compares the patient’s bone density with that of a healthy young adult.
A T-score between -1.0 and -2.5 generally indicates low bone density, sometimes called osteopenia. A T-score of -2.5 or below is consistent with osteoporosis.
Men younger than 50 are usually assessed using a Z-score, which compares their bone density with that of other men of a similar age. A Z-score of -2.0 or lower may suggest that bone density is below the expected range and that an underlying cause should be investigated.
A scan result is only one part of the evaluation. Previous fractures, age, medications, medical conditions, fall risk, and other clinical factors also influence treatment decisions.
There is no universal preventive screening recommendation for all men. Testing is often considered based on age and individual risk.
Many specialty organizations recommend DXA testing for men age 70 and older. Earlier testing may be appropriate for men between 50 and 69 who have significant risk factors.
Testing may also be considered after a low-trauma fracture, prolonged corticosteroid use, substantial height loss, confirmed testosterone deficiency, or diagnosis of a condition associated with bone loss.
Men receiving androgen-deprivation treatment for prostate cancer may require bone-health assessment because treatment can accelerate bone loss.
The timing of repeat testing depends on the initial result, treatment status, age, and expected rate of change.
Not every man with a mildly reduced bone density score needs prescription medication. Treatment is based on the likelihood of a future fracture.
Foundational care may include adequate calcium and vitamin D, resistance exercise, weight-bearing activity, fall prevention, smoking cessation, and limiting excessive alcohol intake.
Calcium is preferably obtained through food when possible. Vitamin D needs may vary according to diet, sun exposure, laboratory results, age, and medical history. Excessive supplementation is not automatically beneficial and may create additional risks.
Resistance training supports muscle strength and balance, while weight-bearing movement helps place appropriate stress on bone. Men with osteoporosis, spinal fractures, significant pain, or balance problems may need professional guidance before beginning high-impact activity.
Prescription medication may be recommended for men with osteoporosis, a hip or spinal fracture, or a high calculated risk of future fracture.
Bisphosphonates are commonly used to slow bone breakdown and reduce fracture risk. Depending on the patient’s health and risk level, other options may include denosumab or medications that stimulate new bone formation.
The best option depends on kidney function, fracture history, dental health, other medications, treatment preferences, and the severity of bone loss.
Some treatments remain active after they are stopped, while others require a carefully planned transition to prevent rapid bone loss. Men should not stop osteoporosis medication without discussing the next step with the prescribing clinician.
Follow-up may include repeat DXA testing, laboratory monitoring, review of side effects, and confirmation that the medication is being taken correctly.
Stronger bones reduce fracture risk, but preventing falls is equally important.
Vision problems, poor balance, muscle weakness, dizziness, sedating medications, loose rugs, and inadequate lighting may increase the chance of falling. Reviewing these risks can be especially important for older men.
Strength and balance exercises, appropriate footwear, home-safety adjustments, and medication review may help reduce falls. Physical therapy may be recommended when weakness, pain, or mobility problems are present.
Reduced bone density can progress without obvious symptoms. Identifying bone loss early creates an opportunity to improve nutrition, preserve muscle, address hormone concerns, and begin medication when fracture risk is high.
Schedule an appointment with Optimal Female & Men’s Wellness to discuss low bone density treatment, testosterone testing, medication review, nutrition, and whether a DXA scan or specialist referral should be included in your care plan.
Reduced bone density means the bones contain less mineral than expected and may be more vulnerable to fractures.
Osteopenia indicates bone density below the normal range. Osteoporosis reflects more advanced bone loss and a greater risk of fractures.
Usually not. Some men develop back pain, height loss, or posture changes after spinal fractures, but bone loss is often silent.
A DXA scan measures bone mineral density, usually at the hip and spine. Results are interpreted with fracture history and other clinical risks.
Testing is commonly considered for men age 70 and older or earlier when significant risk factors, fractures, medications, or medical conditions are present.
The best treatment depends on fracture risk and may include exercise, calcium and vitamin D, fall prevention, prescription medication, and treatment of underlying conditions.
No. Some men need lifestyle support and monitoring, while others may need medication because of a previous fracture or high future risk.
Yes. Medically significant testosterone deficiency may contribute to bone loss, but it must be confirmed through symptoms and appropriate testing.
Not always. Testosterone may support bone density in men with confirmed deficiency, but osteoporosis-specific medication may still be needed when fracture risk is high.
Bone density may stabilize or improve with appropriate nutrition, activity, treatment of contributing conditions, and prescription medication when indicated.